Tag Archives: meaningful use

Guidance for Public Health Agencies Preparing for Stage 2 Meaningful Use

If you hadn’t considered taking a look at what Stage 2 of Meaningful Use has to offer to public health, there is no better time than now. Earlier this week, the Stage 2 Meaningful Use Public Health Reporting Requirements Task Force published a guidance for public health agencies (PHAs) preparing for Stage 2 Meaningful Use (MU).

InteroperabilityAt Stage 2 it’s all about achieving interoperability through common standards among diverse systems and organizations exchanging information.

On September 4, 2012, the Stage 2 Meaningful Use “Final Rules” was published in the Federal Register, requiring local and state Public Health Agencies (PHAs) to ramp-up their MU capabilities and establish new processes to receive the relevant public health data from Eligible Professionals (EPs) and Eligible Hospitals (EHs).

Two important things to highlight for Stage 2 of Meaningful Use:

1) Ongoing submission of electronic data for immunizations is in the core (i.e., mandatory) set for Eligible Professionals and on-going submission of electronic data for immunizations, reportable laboratory results, and syndromic surveillance are in the core set for Eligible Hospitals.

2) EPs have menu (i.e., optional) objectives for reporting syndromic surveillance data, for reporting to cancer registries, and other specialized registries (e.g., birth defects registries, chronic disease registries, traumatic injury registries).

While supporting Stage 2 MU objectives is neither a requirement nor an obligation for PHAs, it is however encouraged. These objectives represent tremendous opportunities for PHAs to improve their surveillance capabilities. Under the Stage 2 MU regulations for the public health objectives, it is suggested that PHAs perform four (4) new administrative tasks to fully support Stage 2.

The Figure listed below (from the Readiness Guidance document), shows these four administrative tasks and the timeline to develop them (prior to the state of Stage 2, 10/01/2013 for EHs and 01/01/2014 for EPs):

Four New Administrative Tasks for PHAs to support MU2

Top Reasons to Read this Document:

  1. Understand the requirements and terminology from the LHD perspective
  2. As a reminder that you need to get up to speed with your state’s MU Stage 2 plans
  3. You will likely be getting questions from your providers very soon

The Task Force developing the Stage 2 MU Public Health Reporting Requirements consists of representatives from the public health community including: NACCHO, ASTHO, ISDS, CSTE, PHII, NAACCR, State PHAs, AIRA, ONC, CDC, and others.

This is the first of many documents that will be developed by this Task Force. Please consider following the efforts of this group.

For more guidance on meaningful use, visit our website and review the resources: http://www.naccho.org/topics/infrastructure/informatics/resources/meaningful-use.cfm.

Advertisements

Getting ready for Stage 2 MU PH Reporting Requirements by the Meaningful Use Public Health Task Force

The Stage 2 Meaningful Use (MU) “Final Rules” published in the Federal Register on September 4, 2012, required local and state Public Health Agencies (PHAs) to ramp-up their MU capabilities and establish new processes to receive the relevant MU-compliant public health data from eligible providers, prior to the start of Stage 2 MU (10/01/2013 for EHs and 01/01/2014 for EPs). In Stage 2 MU, the capability to submit electronic data for immunizations is in the core or mandatory set for Eligible Professionals (EPs) and the capability to submit electronic data for immunizations, reportable laboratory results, and syndromic surveillance is in the core set for Eligible Hospitals (EHs). In addition, two new public health objectives for EPs have been added to the menu or options set – the capability to report cancer cases to a cancer registry and specific cases to a specialized registry (e.g., birth defects registries, chronic disease registries, traumatic injury registries). PHAs preparing for Stage 2 MU will require guidance to implement the new objectives and processes, such as:

  • Contributing their PHA’s MU capacity information to the proposed Centers for Medicare & Medicaid (CMS) centralized PHA capacity repository (declaration process),
  • Supporting providers (EPs and EHs) for registration of their intent to submit data for a MU objective,
  • On-boarding and accepting ongoing data submission from providers; and,
  • Providing an acknowledgement or a written communication (which may be in electronic format) from the PHA confirming a provider’s registration and achievement of ongoing submission.

The Centers for Disease Control & Prevention (CDC) has facilitated the establishment of the Stage 2 MU Public Health Reporting Requirements Task Force with representatives from the public health community; including: NACCHO, ASTHO, JPHIT, ISDS, CSTE, PHII, NAACCR, State PHAs, AIRA, ONC, CDC, and others. This task force is currently working to frame deliverables that will identify key concepts, task flows and guidance for PHAs to implement the Public Health objectives and associated new business processes required for Stage 2 MU. The task force has already provided recommendations and requirements to CMS for the establishment of the centralized PHA capacity repository which will provide EPs and EHs information on jurisdictional capacity to accept electronic data for Stage 2 MU public health objectives. The task force is developing guidance for PHAs to facilitate the registration of intent by providers, on-boarding and ongoing submission, and the ability to provide acknowledgements to providers. The task force is also developing guidance related to transport protocols for the electronic submission of meaningful use data to PHAs. The task force has created a specialized registry work group to provide guidance on how public health agencies can leverage the specialized registry meaningful use objective to obtain case information on mandated public health reporting information such as birth defects, traumatic injuries, hearing and vision and other public health surveillance information.

The consensus guidance and recommendations developed by this collaborative Public Health task force, currently scheduled to be available by April 2013, will be shared widely with state and local PHAs. PHAs across the nation will be able to adopt this guidance according to their jurisdictional needs to implement the new objectives and processes required for Stage 2 MU. For more information on this task force please visit http://www.phconnect.org/group/ph-reporting-task-force, and if interested in providing meaningful contributions to this work, please email meaningfuluse@cdc.gov

Public Health Proposals from ONC’s HIT Policy Committee – October 2012

After Dr. Mostashari’s opening remarks, the HITPC meeting continued with hours of testimony.  Click Here to View October 3, 2012 HITPC Public Health Proposals for Stage 3.